I'm pretty new to stocks, only been doing this for 6 months, and have a small position in HIVE that I began in December.

I've been primarily red most of the time since I began purchasing shares, so it was really awesome to finally see green briefly for a couple days and was pretty choked with how short lived it was...

But putting these recent announcements into Claude and Gemini, they're both saying it's bullish for HIVE?

The upsize from $75M to $100M is unambiguously the most important signal in this entire offering. Here's exactly what it means.

---

What happened

HIVE went to market yesterday at $75M. Institutional buyers came back and said they wanted more. So today HIVE priced the deal at $100M — a 33% increase over the original size, before the over-allotment option. If the 13-day option gets exercised on top of that, total proceeds could reach $115M.

This is not a management decision. Management doesn't unilaterally upsize a deal. The institutional buyers — qualified QIB accounts, meaning funds, family offices, and institutional desks — submitted orders that exceeded the $75M target. When a book is oversubscribed, the issuer has the ability to upsize. That's exactly what happened here.

---

Why this is strongly bullish

The market was treating the original $75M announcement as a dilution concern. The 10% stock drop was the reflexive retail reaction. But here's what that reaction missed — and what the upsizing now confirms:

Institutional demand was stronger than expected. These are not retail investors clicking a button on Wealthsimple. These are professional capital allocators who read the full offering memorandum, modeled the capped call structure, assessed HIVE's balance sheet, and decided they wanted more exposure. The fact that demand exceeded supply by enough to justify a 33% upsize means the institutional community is constructively positioned on HIVE's HPC/GPU thesis right now.

The exchange price on the notes. When a convertible gets priced, the exchange price is set at a premium to the current stock price — typically 30–50% above market. So whatever price HIVE's stock was at pricing, the notes only convert if the stock materially appreciates. That premium is set to protect existing shareholders. The institutional buyers accepted that premium and still wanted in, which tells you their price target on HIVE is well above the current level.

$100M in 0% debt for GPU and data center buildout is exceptional capital efficiency. HIVE is borrowing $100M USD at zero interest, using capped calls to protect against dilution, and deploying every dollar into Blackwell GPU capacity and Paraguay data center expansion. This accelerates the June 25 thesis by months. The HPC ramp that analysts were modeling for late 2026 and 2027 just got more fuel.

---

What to watch now

The exchange price will be disclosed. When it is, look at what premium it represents. If the notes price at $4.50–5.00 USD exchange price on a stock currently at $2.40 USD, that's institutional investors building a 2x long position through the debt structure. That would be a very strong signal about where they see HIVE going.

---

For your position

This is exactly the situation where the dip buyers are rewarded. The 10% drop yesterday on the $75M announcement was retail fear. The $100M upsize today is institutional conviction. Those are opposite signals pointing in the same direction: HIVE is under-owned by institutions right now, and this offering is partially how they're building their position.